Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Health Catalyst Inc (NASDAQ: HCAT) closed at $5.68 in the last session, down -1.56% from day before closing price of $5.77. In other words, the price has decreased by -$1.56 from its previous closing price. On the day, 0.68 million shares were traded. HCAT stock price reached its highest trading level at $5.92 during the session, while it also had its lowest trading level at $5.55.
Ratios:
We take a closer look at HCAT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.41 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 1.03 whereas as Long-Term Debt/Eq ratio is at 0.37.
Evercore ISI Upgraded its In-line to Outperform on January 03, 2024, while the target price for the stock was maintained at $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 15 ’25 when Llewelyn Linda sold 6,442 shares for $5.80 per share. The transaction valued at 37,348 led to the insider holds 92,260 shares of the business.
LINDA LLEWELYN bought 6,442 shares of HCAT for $38,008 on Jan 15 ’25. On Jan 06 ’25, another insider, LeSueur Daniel, who serves as the Chief Operating Officer of the company, sold 5,209 shares for $7.51 each. As a result, the insider received 39,134 and left with 91,253 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCAT now has a Market Capitalization of 345614912 and an Enterprise Value of 328166976. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.14 while its Price-to-Book (P/B) ratio in mrq is 0.97. Its current Enterprise Value per Revenue stands at 1.086 whereas that against EBITDA is -10.229.
Stock Price History:
The Beta on a monthly basis for HCAT is 1.33, which has changed by -0.43871593 over the last 52 weeks, in comparison to a change of 0.23883796 over the same period for the S&P500. Over the past 52 weeks, HCAT has reached a high of $10.99, while it has fallen to a 52-week low of $5.35. The 50-Day Moving Average of the stock is -22.86%, while the 200-Day Moving Average is calculated to be -20.57%.
Shares Statistics:
According to the various share statistics, HCAT traded on average about 619.49K shares per day over the past 3-months and 1015770 shares per day over the past 10 days. A total of 60.85M shares are outstanding, with a floating share count of 58.54M. Insiders hold about 3.80% of the company’s shares, while institutions hold 86.33% stake in the company. Shares short for HCAT as of 1735603200 were 2643994 with a Short Ratio of 4.27, compared to 1732838400 on 2554314. Therefore, it implies a Short% of Shares Outstanding of 2643994 and a Short% of Float of 4.4299997.
